James Rubenstein
Clinical trials sponsored by James Rubenstein, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New antibody combo aims to treat brain lymphoma Results expected Dec 2026 (estimated)
- Could a special MRI spot brain lymphoma without a biopsy? Results expected Mar 2027 (estimated)
-
New antibody combo aims to treat brain lymphoma
Disease control Recruiting nowThis trial investigates a combination of two drugs—tafasitamab, an antibody given by IV, and lenalidomide, an oral medication—for people with relapsed central nervous system (CNS) lymphoma. The study includes up to 35 participants and is the first to test this antibody in CNS lym…
Phase 1/2 • Sponsor: James Rubenstein • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a special MRI spot brain lymphoma without a biopsy?
Diagnosis Recruiting nowThis trial investigates whether a special MRI technique using hyperpolarized carbon-13 pyruvate can safely and effectively detect primary central nervous system lymphoma, a rare type of brain cancer. Participants receive an injection of the substance before an MRI scan, and resea…
Phase 1 • Sponsor: James Rubenstein • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC